Skip to main content

2022 CTOS Annual Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Jaymin M. Patel, MD

Executive Medical Director, Head of Biomarkers

Presentation(s):

Paper 58 - A PHASE IA/IB STUDY OF BOTENSILIMAB, A NOVEL INNATE/ADAPTIVE IMMUNE ACTIVATOR, PLUS BALSTILIMAB FOR THE TREATMENT OF PATIENTS WITH SARCOMA
Friday, November 18, 2022
4:15 PM – 4:23 PM